CAS 1403744-56-8

Begelomab

CAS : 1403744-56-8

Begelomab (SAND-26) is a mouse-derived monoclonal antibody targeting DPP-4/CD26. Begelomab can be used to study severe refractory inflammatory myopathies.

Degré de pureté : 97.8% (SDS-PAGE); 98.3% (SEC-HPLC) - 97.8% (SDS-PAGE); 98.3% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 146.20 kDa

Ref: TM-T76922

Begelomab

CAS : 1403744-56-8

Anti-CD26 monoclonal antibody

Ref: 3D-CLA1365